President And Fellows Of Harvard CollegeThis is an integrated center. The main contribution of Harvard/Wyss will be in the development of manufacturing processes, and fabrication of prototypes.
$379,404
Greenmark Biomedical Inc.Dental Caries (tooth decay) is the world’s most prevalent chronic disease affecting about 96% of Americans over their lifetime. In response, GreenMark…
Revbio, Inc.The goal of this project is to optimize a synthetic, injectable, cohesive organic-mineral bone graft biomaterial with adhesive properties called Tetranite…
$375,777
Greenmark Biomedical Inc.Dental Caries (tooth decay) is the world’s most prevalent chronic disease affecting about 96% of Americans over their lifetime. In response, GreenMark…
President And Fellows Of Harvard CollegeThis is an integrated center. The main contribution of Harvard/Wyss will be in the development of manufacturing processes, and fabrication of prototypes.
$322,854
Ogb3, Inc.The objective of this work is to develop a new class of immunomodulatory therapies ideal for the treatment of periodontal disease and other oral inflammatory…
-$265,016
President And Fellows Of Harvard CollegePeriodontal disease is the leading cause of tooth loss in adults, affecting approximately 50% of the US adult population, with approximately 10% of patients…
$67,048
Trustees Of Tufts CollegeThis project seeks to develop a hydrogel-based system for endodontic regeneration.
$46,787
Amend Surgical, Inc.The goal for the Tissureâ„¢ Project is to conduct robust research and planning, perform extensive prototype testing to refine the specification, conduct…
$873,062
Revbio, Inc.The goal of this project is to optimize a synthetic, injectable, cohesive organic-mineral bone graft biomaterial with adhesive properties called Tetranite…
$224,294
Amend Surgical, Inc.The goal for the Amend Tissue Tapeâ„¢ Project is to complete the feasibility phase (through design freeze). While validations and regulatory submissions…
$1,173,126
Oregon Health & Science UniversityThis is a cooperative agreement. NIDCR and the Operating team for the Michigan-Pittsburgh-Wyss Resource Center chose the ITP team from Tufts/Oregon Health and…
Revbio, Inc.The goal of this project is to optimize a synthetic, injectable, cohesive organic-mineral bone graft biomaterial with adhesive properties called Tetranite…
President And Fellows Of Harvard CollegeThis is an integrated center. The main contribution of Harvard/Wyss will be in the development of manufacturing processes, and fabrication of prototypes.
$2,207,509
Show all 20
Quick answers
Who received award U24DE029462?
U24DE029462 was awarded to Regents Of The University Of Michigan by National Institute of Dental and Craniofacial Research (National Institutes of Health) on May 1, 2020.
How much is award U24DE029462 worth?
$87,594,509 has been obligated on U24DE029462: $81,313,433 in federal funding and $6,281,076 in non-federal funding.